Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.832M Est

Pulmonx (NASDAQ:LUNG) affirms FY2026 sales outlook from $90.000 million-$92.000 million to $90.000 million-$92.000 million vs $90.832 million estimate.